Stay Informed on Corporate Sustainability

Author: Bianca Odron

Eli Lilly’s Foundayo launch highlights how oral GLP-1 medicines could expand treatment access while creating new opportunities for pharmaceutical manufacturing, regulated supply chains and market growth.

Author: Bianca Odron

Queen’s University Belfast researchers develop a dissolvable 3D-printed patch that could enable targeted cancer drug delivery while advancing pharmaceutical manufacturing and personalised medicine.

Author: Bianca Odron

HSE approval of Skyclarys reimbursement marks a positive step for rare disease access, highlighting how pharmaceutical pricing negotiations can support sustainable medicines provision in Ireland.

Author: Bianca Odron

Galen’s Galsana launch brings its rare metabolic disease products under one global identity, supporting international expansion, medical nutrition innovation and future growth across specialist pharmaceutical markets.

Author: Bianca Odron

Bristol Myers Squibb, a leading global biopharmaceutical company with a major biologics manufacturing campus in Cruiserath, Dublin, has been announced as Gold Sponsor of the Pharma Industry Awards 2026, with winners to be announced on 26th November at the Johnstown Estate Hotel. With more than 30,000 employees worldwide and a commitment to discovering and delivering innovative medicines for serious diseases, Bristol Myers Squibb brings both global pharmaceutical scale and deep Irish life sciences investment to the programme.

Author: Bianca Odron

DSV Air & Sea, a global transport and logistics leader committed to keeping customers' supply chains flowing, has been announced as Gold Sponsor of the Pharma Industry Awards UK 2026, taking place on 23rd September at the Park Plaza London Riverbank.

Author: Bianca Odron

Taking a look back at the Life Sciences Industry Awards 2026, Biomimetic Innovations claimed both the Innovation of the Year - Small and Medtech Excellence Awards, recognised for OsStic™, a first-in-class injectable bone bio-adhesive transforming orthopaedic fracture repair.

Author: Bianca Odron

The GLP-1 and biologics boom is stretching pharmaceutical working capital to record levels. For life sciences Ireland, this complexity is an opportunity to lead in supply chain modernisation and manufacturing excellence.

Author: Bianca Odron

SK Pharmteco’s Swords expansion adds commercial small-molecule and high-container HPAPI capacity, strengthening Ireland’s pharmaceutical manufacturing infrastructure and supporting more complex drug development and commercial supply programmes.

Author: Bianca Odron

TMC Pharma Services’ acquisition of tranScrip preserves around 45 specialist jobs while expanding regulatory, medical and scientific capabilities across the UK, Ireland and wider pharmaceutical development market.